MRA
This drug is selected. Its supporting articles are shown below.
Articles mentioning MRA
7 articles · page 1 of 1…ient, with ICERs generally below willingness-to-pay thresholds. Dapagliflozin was cost saving in type 2 diabetes (T2D) in the United Kingdom …
… kidney disease progression by 24% [HR 0.76; 95% CI 0.67–0.87]. Canagliflozin reduced the composite renal outcome [HR 0.66; 95% CI 0.53–0.81]…
…a mineralocorticoid receptor antagonist (MRA), 445 (69.5%) on a RAAS-inhibitor, and 414 (64.7%) on a SGLT2-inhibitor respectively. Overall, 21…
…in TRED-HF received angiotensin receptor–neprilysin inhibitors (ARNIs) or SGLT2 inhibitors, compared with 61% and 63% of TRED-HF2 pat…
…. 93% of patients were on beta blocker. 74% were on MRA, 74% on SGLT2i. 6 patients were readmitted to hospital from VW. The median NT …
…inhibitors or angiotensin receptor-neprilysin inhibitor (ARNI), beta-blockers, mineralocorticoid receptor antagonists (MRA) and sodium-glucos…